Crabb v. Bishop Clarkson Memorial Hospital

591 N.W.2d 756, 256 Neb. 636, 1999 Neb. LEXIS 71
Nebraska Supreme Court·Decided April 2, 1999·No. S-98-798·Published·Cited by 6 cases

Opinion

Wright, J.

NATURE OF CASE

On remand, a single judge (trial court) of the Nebraska Workers’ Compensation Court concluded that there was no legal or factual basis to set aside the trial court’s prior order of dismissal. As a result, the petition filed by Marie A. Crabb was dismissed, and Crabb appeals.

SCOPE OF REVIEW

Before reaching the legal issues presented for review, it is the duty of an appellate court to determine whether it has jurisdiction over the matter before it. Bonge v. County of Madison, 253 Neb. 903, 573 N.W.2d 448 (1998).

FACTS

On January 2, 1990, Crabb was employed by Bishop Clarkson Memorial Hospital (Hospital) when she suffered a needle-stick injury during the course of her employment. In May 1992, while in the process of donating her own blood for use in a later surgery, Crabb learned that she had hepatitis C. On January 15, 1993, Crabb filed an application for workers’ compensation benefits, alleging that the needle-stick injury in 1990 caused her to contract hepatitis C.

At trial, Crabb testified that the needle with which she was stuck was not one she had been using on a patient. She asserted *638 that the needle had been placed on her work tray by someone else and that she had no way of knowing where the needle came from or on which patient the needle had previously been used.

At the time of the needle stick, Crabb was working on the dialysis-transplant floor of the Hospital. She administered first aid to herself and reported the incident to her supervisor. A test of Crabb’s blood done at that time showed she was negative for HIV. There was no test available in January 1990 for a hepatitis C infection.

Dr. Thomas J. Safranek, state epidemiologist for the Nebraska Department of Health, testified on behalf of the Hospital. Safranek identified various risk factors associated with contracting hepatitis C. He stated that the most overwhelming risk factor for hepatitis C is blood transfusions but that other risk categories include intravenous drug use; multiplicity of sexual partners; living in a household with an individual who has hepatitis C; and occupational risks assumed by medical professionals, including dentists, surgeons, and hemodialysis nurses. He also noted that it was documented in the medical literature that transmission of hepatitis C could occur through being tattooed, as well as through other types of percutaneous exposure. Safranek stated that once contracted, the hepatitis C infection can remain undetected for a long period of time.

Crabb’s medical expert, Dr. Michael F. Sorrell, testified by deposition that hepatitis C was primarily transmitted by blood transfusions, blood products, intravenous drug use, and needle sticks. He further stated that there are a number of patients with what are called community-acquired infections, in which the cause of transmission is unknown.

At trial, Crabb denied having blood transfusions at any time in her life. However, records from Ehrling Bergquist Strategic Hospital at Offutt Air Force Base showed that Dr. Edwin C. Schafer had recorded the following on Crabb’s medical history: “She has had multiple head traumas, multiple surgeries for lacerations etc. She had major transfusions in 1975 in Chicago.” In addition, a July 1992 medical report written by Dr. Jeremiah P. Donovan, medical director of hepatic transplantation at the University of Nebraska Medical Center (UNMC), referred *639 repeatedly to prior transfusions: “[S]he had a dogbite at age 2; her scalp bled fairly profusely (and was transfused.) She had blood transfusions again over 20 years ago. She has undergone a blood transfusion as recently as 1992 when she had a total vaginal hysterectomy along with a PREYRA erythroplexy [sic].” Schafer’s and Donovan’s overall impressions were that Crabb had chronic hepatitis C and that there were multiple reasons why she might have developed hepatitis C. Both doctors noted that Crabb had received multiple blood transfusions at times when many of the screening tests for hepatitis C were not available.

The evidence at trial also showed that Crabb had liver tests on June 7, 1982, and March 9, 1989, both prior to the needle stick, which tests showed abnormal liver function. Safranek stated that abnormal liver tests could denote prior liver disease, including a chronic hepatitis C infection. Crabb also admitted she had two tattoos. One was done in 1979 in Denver, and the other was done in 1980 in California. However, Crabb testified that each had been done in a “clean environment.”

Safranek testified that based upon his review of the evidence and the literature about hepatitis C, he was unable to determine within a reasonable degree of medical certainty when Crabb acquired hepatitis C. He stated that his review of Crabb’s medical records from 1982 to 1989 showed abnormal liver function tests

in a consistent fashion without major fluctuations for approximately an eight-year period prior to the needle stick episode. The two times they were tested prior to the needle stick indicated abnormal liver function.
... It suggested to me whatever had been going on had been going on for a number of years ....

Safranek was uncertain whether it was more probable than not that Crabb would have contracted hepatitis C prior to the date of the needle-stick injury. He opined that there were multiple opportunities throughout Crabb’s life when she could have contracted hepatitis C and that it was impossible to say when it occurred.

Sorrell initially opined that Crabb’s hepatitis C was contracted prior to the needle-stick injury. He later reversed this *640 opinion, stating that he had based his original opinion on the fact that Crabb’s liver function tests prior to the time of the needle-stick injury were abnormal. He stated that the elevated liver enzyme reading from 1989 could have been caused by a medication prescribed for Crabb at that time for musculoskeletal complaints. Sorrell opined with a reasonable degree of medical probability that Crabb did contract hepatitis C after an inadvertent needle stick while working in the renal dialysis unit at the Hospital in 1990.

The trial court dismissed Crabb’s petition because she failed to prove that the needle-stick injury caused her to contract hepatitis C, and the dismissal was affirmed by a three-judge review panel of the Workers’ Compensation Court. Crabb appealed to the Nebraska Court of Appeals, which affirmed, and her subsequent motion for rehearing was overruled. This court denied Crabb’s petitions for further review on November 22, 1995.

Free access — add to your briefcase to read the full text and ask questions with AI

Crabb v. Bishop Clarkson Memorial Hospital, 591 N.W.2d 756, 256 Neb. 636, 1999 Neb. LEXIS 71 (Neb. 1999).

591 N.W.2d 756 (Crabb v. Bishop Clarkson Memorial Hospital) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Green v. Drivers Management, Inc.
639 N.W.2d 94 (Nebraska Supreme Court, 2002)
Metro Riverboat Associates, Inc. v. Louisiana Gaming Control Bd.
797 So. 2d 656 (Supreme Court of Louisiana, 2001)
Fay v. Dowding, Dowding & Dowding
623 N.W.2d 287 (Nebraska Supreme Court, 2001)
Armour v. L.H.
608 N.W.2d 599 (Nebraska Supreme Court, 2000)
Slaymaker v. Breyer
607 N.W.2d 506 (Nebraska Supreme Court, 2000)
Hagelstein v. Swift-Eckrich Division of ConAgra
597 N.W.2d 394 (Nebraska Supreme Court, 1999)